Weaver C. Barksdale & Associates’s Esterline Technologies ESL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$11K Buy
153
+26
+20% +$2.14K 0.01% 272
2017
Q3
$11K Buy
127
+18
+17% +$1.62K 0.01% 266
2017
Q2
$10K Sell
109
-14
-11% -$1.3K 0.01% 275
2017
Q1
$11K Hold
123
0.01% 269
2016
Q4
$11K Buy
123
+10
+9% +$818 0.02% 269
2016
Q3
$9K Sell
113
-25
-18% -$1.75K 0.02% 292
2016
Q2
$9K Buy
138
+20
+17% +$1.31K 0.02% 273
2016
Q1
$8K Buy
118
+33
+39% +$2.17K 0.01% 320
2015
Q4
$7K Sell
85
-19
-18% -$1.55K 0.01% 338
2015
Q3
$7K Buy
104
+5
+5% +$426 0.01% 333
2015
Q2
$9K Buy
99
+14
+16% +$1.5K 0.01% 302
2015
Q1
$10K Hold
85
0.01% 287
2014
Q4
$9K Buy
85
+5
+6% +$562 0.01% 293
2014
Q3
$9K Hold
80
0.01% 288
2014
Q2
$9K Hold
80
0.01% 294
2014
Q1
$9K Sell
80
-18
-18% -$1.9K 0.01% 290
2013
Q4
$10K Hold
98
0.01% 279
2013
Q3
$8K Sell
98
-14
-13% -$1.12K 0.01% 321
2013
Q2
$8K Buy
+112
New +$8.31K 0.01% 314

Other funds holding ESL

Weaver C. Barksdale & Associates's ESL Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Esterline Technologies (ESL) stake by 20% in Q4 2017, buying an estimated $2.14K and bringing the position to 153 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #272.

Weaver C. Barksdale & Associates first reported a position in ESL in Q2 2013 and has held it in 19 quarters since. 217 funds tracked by Wall St. Rank hold ESL as of Q4 2017.

  • Weaver C. Barksdale & Associates held 153 shares of Esterline Technologies worth $11K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 26 Esterline Technologies shares in Q4 2017, an estimated $2.14K.
  • Esterline Technologies made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #272 holding.
  • Weaver C. Barksdale & Associates first reported a position in Esterline Technologies in Q2 2013 and has held it in 19 quarters since.
  • 217 funds tracked by Wall St. Rank held Esterline Technologies as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.